Paradigm Biocapital Advisors LP 13D and 13G filings for Vor Biopharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:33 pm Sale | 2024-09-30 | 13G | Vor Biopharma Inc. VOR | Paradigm Biocapital Advisors LP | 0 0.000% | -6,457,293 (Position Closed) | Filing |
| 2024-02-14 4:08 pm Sale | 2023-12-31 | 13G | Vor Biopharma Inc. VOR | Paradigm Biocapital Advisors LP | 6,457,293 9.500% | -20,706 (-0.32%) | Filing |
| 2023-02-14 4:55 pm Purchase | 2022-12-31 | 13G | Vor Biopharma Inc. VOR | Paradigm Biocapital Advisors LP | 6,477,999 9.900% | 4,149,505 (+178.21%) | Filing |
| 2022-10-27 4:47 pm Purchase | 2022-10-17 | 13G | Vor Biopharma Inc. VOR | Paradigm Biocapital Advisors LP | 2,328,494 6.100% | 2,328,494 (New Position) | Filing |